(MOH) Molina Healthcare - Overview

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US60855R1005

Stock: Managed Care, Medicaid, Medicare, Marketplace

Total Rating 35

Risk 85

Buy Signal -0.97

Healthcare Plans » Managed Health Care
Age: 22.6y

Market Cap: 9,820m
Avg Trading Vol: 241M USD

ATR: 3.96%
Peers RS (IBD): 17.14

EPS (Earnings per Share)

EPS CAGR: -46.85%
EPS Trend: -43.7%

Last SUE: -0.62
Qual. Beats: 0

Revenue

Rev. CAGR: 12.38%
Rev. Trend: 98.0%

Last SUE: 2.74
Qual. Beats: 5

Risk 5d forecast
Volatility	72.3%
Relative Tail Risk	-14.6%

Reward TTM
Sharpe Ratio	-1.09
Alpha	-62.77

Character TTM
Beta	0.019
Beta Downside	-0.105

Drawdowns 3y
Max DD	68.60%
CAGR/Max DD	-0.36

Description: MOH Molina Healthcare January 06, 2026

Molina Healthcare (MOH) is a U.S.-based managed-care insurer that primarily serves low-income individuals through Medicaid, Medicare, and state-run insurance marketplaces. Founded in 1980 and headquartered in Long Beach, California, the company organizes its operations into four segments: Medicaid, Medicare, Marketplace, and Other.

As of FY 2023, Molina reported approximately 5.3 million total members, with Medicaid accounting for roughly 70 % of the enrollment base. Revenue reached about $5.1 billion, delivering an operating margin near 3.5 % and generating $250 million of cash from operations. Key drivers include continued Medicaid expansion in several states, strong growth in Medicare Advantage enrollments (≈10 % YoY), and the broader sector trend of rising healthcare cost inflation, which pressures reimbursement rates but also expands the market for cost-containment solutions.

For a deeper quantitative dive into Molina’s valuation dynamics, you may find ValueRay’s analyst toolkit useful for uncovering hidden upside and risk factors.

Piotroski VR‑10 (Strict, 0-10) 5.0

Net Income: 883.0m TTM > 0 and > 6% of Revenue
FCF/TA: -0.04 > 0.02 and ΔFCF/TA -4.25 > 1.0
NWC/Revenue: 11.38% < 20% (prev 11.59%; Δ -0.21% < -1%)
CFO/TA -0.03 > 3% & CFO -461.0m > Net Income 883.0m
Net Debt (-369.0m) to EBITDA (1.52b): -0.24 < 3
Current Ratio: 1.68 > 1.5 & < 3
Outstanding Shares: last quarter (53.6m) vs 12m ago -7.11% < -2%
Gross Margin: 10.07% > 18% (prev 0.12%; Δ 995.3% > 0.5%)
Asset Turnover: 283.3% > 50% (prev 248.8%; Δ 34.50% > 0%)
Interest Coverage Ratio: 7.60 > 6 (EBITDA TTM 1.52b / Interest Expense TTM 174.0m)

Altman Z'' 3.81

A: 0.32 (Total Current Assets 12.55b - Total Current Liabilities 7.48b) / Total Assets 15.70b
B: 0.24 (Retained Earnings 3.76b / Total Assets 15.70b)
C: 0.08 (EBIT TTM 1.32b / Avg Total Assets 15.73b)
D: 0.33 (Book Value of Equity 3.77b / Total Liabilities 11.51b)
Altman-Z'' Score: 3.81 = AA

Beneish M -2.66

DSRI: 0.95 (Receivables 3.52b/3.26b, Revenue 44.55b/39.20b)
GMI: 1.18 (GM 10.07% / 11.90%)
AQI: 1.10 (AQ_t 0.18 / AQ_t-1 0.16)
SGI: 1.14 (Revenue 44.55b / 39.20b)
TATA: 0.09 (NI 883.0m - CFO -461.0m) / TA 15.70b)
Beneish M-Score: -2.66 (Cap -4..+1) = A

What is the price of MOH shares?

As of February 07, 2026, the stock is trading at USD 131.72 with a total of 10,331,485 shares traded.
Over the past week, the price has changed by -26.66%, over one month by -28.70%, over three months by -10.47% and over the past year by -53.78%.

Is MOH a buy, sell or hold?

Molina Healthcare has received a consensus analysts rating of 3.75. Therefor, it is recommend to hold MOH.

StrongBuy: 6
Buy: 1
Hold: 8
Sell: 1
StrongSell: 0

What are the forecasts/targets for the MOH price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	186.7	41.7%
Analysts Target Price	186.7	41.7%
ValueRay Target Price	120.6	-8.4%

MOH Fundamental Data Overview February 04, 2026

P/E Trailing = 11.1633
P/E Forward = 12.837
P/S = 0.2292
P/B = 2.2026
P/EG = 2.7891
Revenue TTM = 44.55b USD
EBIT TTM = 1.32b USD
EBITDA TTM = 1.52b USD
Long Term Debt = 3.66b USD (from longTermDebt, last quarter)
Short Term Debt = 15.0m USD (from shortTermDebt, last fiscal year)
Debt = 3.85b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -369.0m USD (from netDebt column, last quarter)
Enterprise Value = 9.45b USD (9.82b + Debt 3.85b - CCE 4.22b)
Interest Coverage Ratio = 7.60 (Ebit TTM 1.32b / Interest Expense TTM 174.0m)
EV/FCF = -16.47x (Enterprise Value 9.45b / FCF TTM -574.0m)
FCF Yield = -6.07% (FCF TTM -574.0m / Enterprise Value 9.45b)
FCF Margin = -1.29% (FCF TTM -574.0m / Revenue TTM 44.55b)
Net Margin = 1.98% (Net Income TTM 883.0m / Revenue TTM 44.55b)
Gross Margin = 10.07% ((Revenue TTM 44.55b - Cost of Revenue TTM 40.06b) / Revenue TTM)
Gross Margin QoQ = 8.08% (prev 10.21%)
Tobins Q-Ratio = 0.60 (Enterprise Value 9.45b / Total Assets 15.70b)
Interest Expense / Debt = 1.27% (Interest Expense 49.0m / Debt 3.85b)
Taxrate = 10.23% (9.00m / 88.0m)
NOPAT = 1.19b (EBIT 1.32b * (1 - 10.23%))
Current Ratio = 1.68 (Total Current Assets 12.55b / Total Current Liabilities 7.48b)
Debt / Equity = 0.92 (Debt 3.85b / totalStockholderEquity, last quarter 4.19b)
Debt / EBITDA = -0.24 (Net Debt -369.0m / EBITDA 1.52b)
Debt / FCF = 0.64 (negative FCF - burning cash) (Net Debt -369.0m / FCF TTM -574.0m)
Total Stockholder Equity = 4.40b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.61% (Net Income 883.0m / Total Assets 15.70b)
RoE = 20.07% (Net Income TTM 883.0m / Total Stockholder Equity 4.40b)
RoCE = 16.41% (EBIT 1.32b / Capital Employed (Equity 4.40b + L.T.Debt 3.66b))
RoIC = 15.26% (NOPAT 1.19b / Invested Capital 7.78b)
WACC = 4.62% (E(9.82b)/V(13.67b) * Re(5.98%) + D(3.85b)/V(13.67b) * Rd(1.27%) * (1-Tc(0.10)))
Discount Rate = 5.98% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -4.03%
Fair Price DCF = unknown (Cash Flow -574.0m)
EPS Correlation: -43.73 | EPS CAGR: -46.85% | SUE: -0.62 | # QB: 0
Revenue Correlation: 97.99 | Revenue CAGR: 12.38% | SUE: 2.74 | # QB: 5
EPS next Quarter (2026-03-31): EPS=3.70 | Chg30d=+0.031 | Revisions Net=-4 | Analysts=4
EPS next Year (2026-12-31): EPS=12.40 | Chg30d=-0.124 | Revisions Net=-6 | Growth EPS=+6.3% | Growth Revenue=+4.0%

Additional Sources for MOH Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Fund Manager Positions: Dataroma | Stockcircle